Repository logo
Communities & Collections
All of DSpace
  • English
  • العربية
  • বাংলা
  • Català
  • Čeština
  • Deutsch
  • Ελληνικά
  • Español
  • Suomi
  • Français
  • Gàidhlig
  • हिंदी
  • Magyar
  • Italiano
  • Қазақ
  • Latviešu
  • Nederlands
  • Polski
  • Português
  • Português do Brasil
  • Srpski (lat)
  • Српски
  • Svenska
  • Türkçe
  • Yкраї́нська
  • Tiếng Việt
Log In
New user? Click here to register.Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Thalagala, N.I."

Filter results by typing the first few letters
Now showing 1 - 1 of 1
  • Results Per Page
  • Sort Options
  • No Thumbnail Available
    Item
    Nottingham grade 2 breast cancer; is it a true prognostic category?
    (Faculty of Medicine, University of Kelaniya, Sri Lanka, 2016) Peiris, H.H.; Mudduwa, L.K.B.; Thalagala, N.I.; Jayatilake, K.A.P.W.
    BACKGROUND: Nottingham grade (NG) is a well-recognized prognostic factor derived by adding scores (1-3) given for three histological features of breast cancer (BC). NG is assigned according to the final score (NG1=score 3-5, NG2=score 6-7, NG3=score 8-9) where NG1 has the best and NG3 has the worst prognosis. OBJECTIVE: To assess whether the NG2 entails only patients with a similar prognosis. METHODS: Data were collected from all NG2 BC patients who had sought the services of our unit from 2006 to 2012. Grading was done by a single investigator. Patients were divided into two groups according to the score assigned in grading (6 and 7) and followed up with a mean follow-up time of 45 (SD=23) months. Clinico-pathological features were compared using chi-square test. Kaplan-Meier model with log-rank test was used for survival analysis. RESULTS: The study included 352 NG2 BC patients (score 6=195; score 7=157) with a mean age of 52 (SD=11) years. Majority of the patients with score 6 had ER/PR positive tumours (p=0.007 and 0.029) whereas score 7 patients had Her 2 positive tumours (p=0.002). There was a significant survival difference between the patients who had scores 6 and 7 (breast cancer specific survival p=0.007; recurrence free survival p=0.019). There was no survival difference between the patients with NG1 and score 6 and NG3 and score 7 (p>0.05). CONCLUSIONS: NG2 comprises two subsets of patients with a significant survival difference. Their prognosis is more in line with the preceding/subsequent grade than the same grade, probably due to the difference in ER/PR and Her 2 expression.

DSpace software copyright © 2002-2025 LYRASIS

  • Privacy policy
  • End User Agreement
  • Send Feedback
Repository logo COAR Notify